Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Return on Invested Capital (2020 - 2024)

Celularity has reported Return on Invested Capital over the past 5 years, most recently at 0.7% for Q3 2024.

  • Quarterly results put Return on Invested Capital at 0.7% for Q3 2024, up 139.0% from a year ago — trailing twelve months through Sep 2024 was 0.7% (up 139.0% YoY), and the annual figure for FY2023 was 1.29%, down 114.0%.
  • Return on Invested Capital for Q3 2024 was 0.7% at Celularity, up from 3.51% in the prior quarter.
  • Over the last five years, Return on Invested Capital for CELU hit a ceiling of 0.3% in Q3 2021 and a floor of 3.66% in Q4 2023.
  • Median Return on Invested Capital over the past 5 years was 0.49% (2022), compared with a mean of 1.02%.
  • Biggest five-year swings in Return on Invested Capital: plummeted -354bps in 2023 and later surged 139bps in 2024.
  • Celularity's Return on Invested Capital stood at 0.01% in 2020, then tumbled by -10128bps to 1.12% in 2021, then skyrocketed by 90bps to 0.12% in 2022, then plummeted by -3047bps to 3.66% in 2023, then skyrocketed by 81bps to 0.7% in 2024.
  • The last three reported values for Return on Invested Capital were 0.7% (Q3 2024), 3.51% (Q2 2024), and 2.95% (Q1 2024) per Business Quant data.